FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2278470648> ?p ?o ?g. }

• W2278470648 endingPage "454" @default.
• W2278470648 startingPage "449" @default.
• W2278470648 abstract "Background Minimal residual disease (MRD) is defined as the presence of sub-microscopic levels of leukaemia. Measurement of MRD from bone marrow at the end of induction chemotherapy (day 28) for childhood acute lymphoblastic leukaemia (ALL) can highlight a large group of patients (>40%) with an excellent (>90%) short-term event-free survival (EFS). However, follow-up in recent published trials is relatively short, raising concerns about using this result to infer the safety of further therapy reduction in the future. Methods We examined MRD data on 225 patients treated on one of three UKALL trials between 1997 and 2003 to assess the long-term (>10 years follow-up) outcome of those patients who had low-risk MRD (<0.01%) at day 28. Results Our pilot data define a cohort of 53% of children with MRD <0.01% at day 28 who have an EFS of 91% and long-term overall survival of 97%. Of 120 patients with day-28 MRD <0.01% and extended follow-up, there was one death due to treatment-related toxicity, one infectious death while in complete remission, and four relapse deaths. Conclusions The excellent outcome for childhood ALL in patients with MRD <0.01% after induction chemotherapy is sustained for more than 10 years from diagnosis. This supports the potential exploration of further reduction of therapy in this group, in an attempt to reduce treatment-related mortality and late effects." @default.
• W2278470648 created "2016-06-24" @default.
• W2278470648 creator A5001836891 @default.
• W2278470648 creator A5009877179 @default.
• W2278470648 creator A5013867832 @default.
• W2278470648 creator A5030646889 @default.
• W2278470648 creator A5050141938 @default.
• W2278470648 creator A5066319509 @default.
• W2278470648 creator A5071432225 @default.
• W2278470648 creator A5083456305 @default.
• W2278470648 creator A5090938450 @default.
• W2278470648 date "2016-02-10" @default.
• W2278470648 modified "2023-10-16" @default.
• W2278470648 title "Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997–2003" @default.
• W2278470648 cites W1209942950 @default.
• W2278470648 cites W1485389706 @default.
• W2278470648 cites W1968659469 @default.
• W2278470648 cites W1986395681 @default.
• W2278470648 cites W1989485003 @default.
• W2278470648 cites W2003563966 @default.
• W2278470648 cites W2008583458 @default.
• W2278470648 cites W2014561096 @default.
• W2278470648 cites W2033439695 @default.
• W2278470648 cites W2035166663 @default.
• W2278470648 cites W2038604255 @default.
• W2278470648 cites W2038978021 @default.
• W2278470648 cites W2057388030 @default.
• W2278470648 cites W2060033869 @default.
• W2278470648 cites W2067607205 @default.
• W2278470648 cites W2071899049 @default.
• W2278470648 cites W2078124251 @default.
• W2278470648 cites W2089624490 @default.
• W2278470648 cites W2094395262 @default.
• W2278470648 cites W2097732803 @default.
• W2278470648 cites W2098908574 @default.
• W2278470648 cites W2118526609 @default.
• W2278470648 cites W2119093632 @default.
• W2278470648 cites W2148631711 @default.
• W2278470648 cites W2148725398 @default.
• W2278470648 cites W2151069914 @default.
• W2278470648 cites W2158284820 @default.
• W2278470648 cites W2159325547 @default.
• W2278470648 cites W2163926478 @default.
• W2278470648 cites W2314097375 @default.
• W2278470648 cites W4375906968 @default.
• W2278470648 doi "https://doi.org/10.1136/archdischild-2015-309617" @default.
• W2278470648 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26865705" @default.
• W2278470648 hasPublicationYear "2016" @default.
• W2278470648 type Work @default.
• W2278470648 sameAs 2278470648 @default.
• W2278470648 citedByCount "22" @default.
• W2278470648 countsByYear W22784706482016 @default.
• W2278470648 countsByYear W22784706482017 @default.
• W2278470648 countsByYear W22784706482018 @default.
• W2278470648 countsByYear W22784706482019 @default.
• W2278470648 countsByYear W22784706482020 @default.
• W2278470648 countsByYear W22784706482021 @default.
• W2278470648 countsByYear W22784706482022 @default.
• W2278470648 countsByYear W22784706482023 @default.
• W2278470648 crossrefType "journal-article" @default.
• W2278470648 hasAuthorship W2278470648A5001836891 @default.
• W2278470648 hasAuthorship W2278470648A5009877179 @default.
• W2278470648 hasAuthorship W2278470648A5013867832 @default.
• W2278470648 hasAuthorship W2278470648A5030646889 @default.
• W2278470648 hasAuthorship W2278470648A5050141938 @default.
• W2278470648 hasAuthorship W2278470648A5066319509 @default.
• W2278470648 hasAuthorship W2278470648A5071432225 @default.
• W2278470648 hasAuthorship W2278470648A5083456305 @default.
• W2278470648 hasAuthorship W2278470648A5090938450 @default.
• W2278470648 hasConcept C126322002 @default.
• W2278470648 hasConcept C187212893 @default.
• W2278470648 hasConcept C2776611710 @default.
• W2278470648 hasConcept C2776694085 @default.
• W2278470648 hasConcept C2778461978 @default.
• W2278470648 hasConcept C2779823535 @default.
• W2278470648 hasConcept C2780007613 @default.
• W2278470648 hasConcept C2781107101 @default.
• W2278470648 hasConcept C2909962599 @default.
• W2278470648 hasConcept C71924100 @default.
• W2278470648 hasConcept C72563966 @default.
• W2278470648 hasConceptScore W2278470648C126322002 @default.
• W2278470648 hasConceptScore W2278470648C187212893 @default.
• W2278470648 hasConceptScore W2278470648C2776611710 @default.
• W2278470648 hasConceptScore W2278470648C2776694085 @default.
• W2278470648 hasConceptScore W2278470648C2778461978 @default.
• W2278470648 hasConceptScore W2278470648C2779823535 @default.
• W2278470648 hasConceptScore W2278470648C2780007613 @default.
• W2278470648 hasConceptScore W2278470648C2781107101 @default.
• W2278470648 hasConceptScore W2278470648C2909962599 @default.
• W2278470648 hasConceptScore W2278470648C71924100 @default.
• W2278470648 hasConceptScore W2278470648C72563966 @default.
• W2278470648 hasIssue "5" @default.
• W2278470648 hasLocation W22784706481 @default.
• W2278470648 hasLocation W22784706482 @default.
• W2278470648 hasOpenAccess W2278470648 @default.
• W2278470648 hasPrimaryLocation W22784706481 @default.
• W2278470648 hasRelatedWork W1905742279 @default.
• W2278470648 hasRelatedWork W2034028172 @default.

• next